MARIA SOLON: Open Payments
NPI 1497069041 · LINDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 26 payments from 14 companies in 2025. Trend: 2023 $406 · 2024 $801 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $159 |
| CVRx, Inc. | 1 | $135 |
| Alnylam Pharmaceuticals Inc. | 4 | $70 |
| Merck Sharp & Dohme LLC | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Abbott Laboratories | 1 | $34 |
| AtriCure, Inc. | 1 | $30 |
| Impulse Dynamics (USA) Inc. | 1 | $23 |
Products named: JARDIANCE, Barostim Neo System, VERQUVO, AMVUTTRA, LEQVIO, Kerendia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ATRICLIP LAA EXCLUSION SYSTEM.
Industry payments across NJ — which companies pay providers there.
